์ฃผ์š” ์ฝ˜ํ…์ธ ๋กœ ๊ฑด๋„ˆ๋›ฐ๊ธฐ

๊ท€ํ•˜์˜ ๋ธŒ๋ผ์šฐ์ €๊ฐ€ ์™„๋ฒฝํ•˜๊ฒŒ ์ง€์›๋˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค. ์˜ต์…˜์ด ์žˆ๋Š” ๊ฒฝ์šฐ ์ตœ์‹  ๋ฒ„์ „์œผ๋กœ ์—…๊ทธ๋ ˆ์ด๋“œํ•˜๊ฑฐ๋‚˜ Mozilla Firefox, Microsoft Edge, Google Chrome ๋˜๋Š” Safari 14 ์ด์ƒ์„ ์‚ฌ์šฉํ•˜์„ธ์š”. ๊ฐ€๋Šฅํ•˜์ง€ ์•Š๊ฑฐ๋‚˜ ์ง€์›์ด ํ•„์š”ํ•œ ๊ฒฝ์šฐ ํ”ผ๋“œ๋ฐฑ์„ ๋ณด๋‚ด์ฃผ์„ธ์š”.

์ด ์ƒˆ๋กœ์šด ๊ฒฝํ—˜์— ๋Œ€ํ•œ ๊ท€ํ•˜์˜ ์˜๊ฒฌ์— ๊ฐ์‚ฌ๋“œ๋ฆฝ๋‹ˆ๋‹ค.์˜๊ฒฌ์„ ๋ง์”€ํ•ด ์ฃผ์„ธ์š”์ƒˆ ํƒญ/์ฐฝ์—์„œ ์—ด๊ธฐ

Elsevier
์—˜์Šค๋น„์–ด์™€ ํ•จ๊ป˜ ์ถœํŒ

ํ”„๋กœํ•„

Joel Richter

Joel Richter

University of Massachusetts Chan Medical School, USA

Joel D. Richter is a Professor of Molecular Medicine and the Arthur F. Koskinas Professor in Neuroscience at the University of Massachusetts Chan Medical School. Richter and his laboratory defined cytoplasmic polyadenylation and the RNA binding protein CPEB as being instrumental in translational control in early development and in the brain. More recently, they have demonstrated that Fragile X Syndrome, a neurodevelopmental disorder, is in part caused by mis-splicing of FMR1 RNA. This mis-splicing event is corrected by antisense oligonucleotide (ASO) administration, suggesting a possible novel therapeutic advance to treat this disease.

Website pageopens in new tab/window